Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger - A prospective study

Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger - A prospective study
复制标题

DOI:
10.1001/jama.276.7.544
复制
发表时间:
1996-08-21
影响因子:
120.7
通讯作者:
Castelli, WP
Castelli, WP
中科院分区:
医学1区
文献类型:
--
作者:
Bostom, AG;Cupples, LA;Castelli, WP

文献摘要

被引文献

相似文献

客观。-为了确定是否脂蛋白(a)[Lp(a)]升高,检测作为一个下沉的前β-脂蛋白带电泳的新鲜血浆,是一个独立的危险因素,为早发冠心病(CHD)的发展在男性。对Fraketan后代队列的前瞻性研究。在1971年至1975年期间,共有2191名年龄在20至54岁之间的男性接受了心血管疾病检查。55岁以下冠心病(心肌梗死、冠状动脉功能不全、心绞痛或心源性猝死)的发生率。在中位随访15.4年后,有129例CHD事件。相对风险(RR)估计(95%置信区间[Cls])来自比例风险模型,包括年龄、体重指数和二分风险因素协变量,血浆Lp(a)水平升高,总胆固醇水平6.2 mmol/L(240 mg/dL)或更高,高密度脂蛋白(HDL)水平低于0.9 mmol/L(35 mg/dL)、吸烟、葡萄糖耐量异常和高血压患者的Lp(a)水平升高,RR为1.9(95% CI,1.2-2.9),患病率,11.3%;总胆固醇水平≥ 6.2 mmol/L,RR,1.8(95%CI,1.2-2.7),患病率,14.3%; HDL水平低于0.9 mmol/L,RR,1.8(95% CI,1.2-2.6),患病率,19.2%;吸烟,RR,3.6(95% CI,2.2-5.5),患病率,46.7%;葡萄糖耐受不良,RR,2.7(95%CI,1.4-5.3),患病率,2.6%;高血压,RR,1.2(95%CI,0.8-1.8),患病率,26.3%。血浆Lp(a)升高是男性早发CHD的独立危险因素,其程度和患病率(即归因风险)与总胆固醇水平≥ 6.2 mmol/L(240 mg/dL)或HDL水平低于0.9 mmol/L(35 mg/dL)相当。
Objective.-To establish whether elevated lipoprotein(a) [Lp(a)], detected as a sinking pre-beta-lipoprotein band on electrophoresis of fresh plasma, is an independent risk factor for the development of premature coronary heart disease (CHD) in men.Design and Setting.-Prospective study of the Framingham offspring cohort.Participants.-A total of 2191 men aged 20 to 54 years old who were free of cardiovascular disease when they were examined between 1971 and 1975.Main Outcome Measures.-Incident CHD (myocardial infarction, coronary insufficiency, angina pectoris, or sudden cardiac death) occurring by age 55 years.Results.-After a median follow-up of 15.4 years, there were 129 CHD events. The relative risk (RR) estimates (with 95% confidence intervals [Cls]) for premature CHD derived from a proportional hazards model that included age, body mass index, and the dichotomized risk factor covariables elevated plasma Lp(a) level, total cholesterol level of 6.2 mmol/L (240 mg/dL) or more, high-density lipoprotein (HDL) level less than 0.9 mmol/L (35 mg/dL), smoking, glucose intolerance, and hypertension were as follows: elevated Lp(a) level, RR, 1.9 (95% Cl, 1.2-2.9), prevalence, 11.3%; total cholesterol level of 6.2 mmol/L or more, RR, 1.8 (95% Cl, 1.2-2.7), prevalence, 14.3%; HDL level of less than 0.9 mmol/L, RR, 1.8 (95% Cl, 1.2-2.6), prevalence, 19.2%; smoking, RR, 3.6 (95% Cl, 2.2-5.5), prevalence, 46.7%; glucose intolerance, RR, 2.7 (95% Cl, 1.4-5.3), prevalence, 2.6%; hypertension, RR, 1.2 (95% Cl, 0.8-1.8), prevalence, 26.3%.Conclusions.-Elevated plasma Lp(a) is an independent risk factor for the development of premature CHD in men, comparable in magnitude and prevalence (ie, attributable risk) to a total cholesterol level of 6.2 mmol/L (240 mg/dL) or more, or an HDL level less than 0.9 mmol/L (35 mg/dL).